Altamont Capital Partners Invests in Key Container Corporation
Investment to position Key Container as a leader in the Northeast
Key Container provides specialty and custom corrugated packaging products and services to customers across the Northeast. The company, founded in 1959 by
"We are excited to partner with Altamont as we continue to support our customers with their packaging needs," said
"Over the past six decades, Key Container has established itself as a regional manufacturing leader," said
"As a family-run company with stellar fundamentals operating in an industry with stable and attractive long-term growth, Key Container is precisely the kind of opportunity that we see as having terrific potential to scale," said
Terms of the transaction were not disclosed. Jefferies Financial Group acted as the exclusive financial advisor for Altamont. For Key Container, TM Capital – A Division of Capstone Partners acted as the exclusive financial advisor.
About Altamont Capital Partners
Founded in 2010, Altamont Capital Partners ("Altamont") is a private equity firm focused on transforming and scaling lower-middle market companies through significant business-building and value-creation resources. Altamont makes long-term, control investments in sectors where we have deep experience and specialized knowledge, and partners with management teams to execute proven and repeatable platform-building playbooks. Since inception, Altamont has invested in over 45 companies operating across the Industrials, Business Services and Financial Services. Altamont currently manages over
About Key Container Corporation
Founded in 1959, Key Container Corporation ("Key Container") provides corrugated packaging products and services to companies in
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/altamont-capital-partners-invests-in-key-container-corporation-302707438.html
SOURCE Altamont Capital Partners
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Positive interim analysis advances Avecho Phase III insomnia program
- Share buybacks in Ericsson during the period June 22 - June 26, 2026
- TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share